‘Closer to US commercialisation’ – EBR achieves major FDA milestone
US FDA completes initial filing review of EBR’s PMA application, determines it contains all required information to proceed to a substantive review PMA application [more…]
Magnetic Resources raises $10m to advance low-cost and high-value Lady Julie gold project
Magnetic to raise A$10m via placement at A$1.25 per share Placement supported by multiple specialist resources funds Funds will support resource expansion and feasibility work [more…]
Resources Top 5: Just about all ressie commodities have a winner today
Australian Rare Earths’ Koppamurra resource increases 27% to 236Mt at 748ppm TREO Alderan eyes 28% copper at New Year prospect Hazer completes 360 hours of [more…]
ASX Small Caps Lunch Wrap: Benchmark moves to record highs as iron ore momentum builds
The ASX 200 benchmark has hit record a intraday high today, 8,278.6 points at 12pm Iron ore prices have driven Materials stocks to very healthy [more…]
Trigg gets its hands on huge Achilles antimony project
Trigg Minerals signs agreement to purchase 100% of the Achilles project which contains the globally significant high-grade and high-tonnage Wild Cattle Creek Antimony Deposit It’s [more…]
Break it Down: Lithium Universe’s refinery PFS
Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds. In this episode, host Sarah Hughan tells all on Lithium Universe’s [more…]
Rumble Resources gets huge strategic backer
Rumble Resources gets $1m investment from Bain Resources Holdings (BRH) BRH is associated with major Indian mining contractor, BGR Mining and Infra Limited The company [more…]
Health Check: Probiotics supplier has gut feeling about surging growth
Biome Australia believes it can almost quadruple its probiotics revenue over next three years Anteris faces delay to proposed Nasdaq listing and IPO Artrya asks [more…]
Top 10 at 11: Exploration and fundraising is exciting the market this morning
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning [more…]
Long Shortz with PharmAust: Sweet incentives for sad disease’s drug development
Stockhead’s Sarah Hughan sits down with PharmAust (ASX:PAA) managing director Dr Michael Thurn to get the short end of the long story on the company’s [more…]
